SUMMARY
Halothane has been reported to produce negative inotropic effects in vivo [1] and in vitro [2] and has been observed to sensitize the myocardium to the pro-arrhythmic effects of exogenous catecholamines [3] . Although these effects are important clinically, the cellular mechanisms are not completely understood [4, 5] . The present study was designed to see if examination of positive inotropic agents (with different mechanisms) alone and in the presence of halothane could provide evidence for specific •interactions on different subcellular targets and if the effects are non-specific, by potential membrane depressant effects of the inhalation anaesthetics by disturbing the structure of the membrane [6] . In addition, we studied the influence of halothane on the potency and efficacy of noradrenaline, the phosphodiesterase inhibitor, milrinone, the L-type Ca 2+ channel agonist, BayK 8644, and Ca
2+
. Isolated electrically stimulated cardiac preparations were used because in this model inotropic effects can be studied without interference from changes in pre-or afterload or heart rate.
MATERIALS AND METHODS

Human myocardial tissue
Left ventricular myocardium from 13 terminally failing hearts (10 male, three female; aged 19-67 yr) was obtained from patients after cardiectomy during cardiac transplantation. The preoperative diagnosis was dilated cardiomyopathy in all patients. All patients gave written informed consent before operation. Drugs used for general anaesthesia included flunitrazepam or midazolam, fentanyl and pancuronium with isoflurane. Cardiac surgery was performed with cardiopulmonary bypass and hypothermia. The cardioplegic solution used was a modified Bretschneider solution containing (mmol litre" 1 ): NaCl 15; KC1 10; MgCl 2 4; histidine HC1 180; tryptophan 2; mannitol 30; potassium dihydrogen oxoglutarate 1.
Isolated cardiac preparation and measurement of force of contraction
Immediately after excision, the papillary muscle strips were placed in ice-cold pre-aerated Tyrode solution and delivered to the laboratory within 10 min. Each native papillary muscle was split into thin strips (less than 1 mm thick and 6-9 mm long) with the muscle fibres running approximately parallel to the length of the strips. The muscles were suspended in an organ bath (75 ml) maintained at 37 °C and containing a modified 
Halothane concentrations
Halothane was administered with a Vapor 19 (Drager CO, Liibeck, Germany) to the carbogen (95% oxygen +5% carbon dioxide) and bubbled into the organ baths. A concentration of 0-^4% (0-0.75 mmol litre" 1 ) was added to the carbogen. The concentration of halothane in the bathing solution was measured by gas chromatography using headspace analysis. Separation was made on a 60-m capillary column (RTX 1701, id 530 urn). The correlation between the concentration of halothane added to the carbogen and that in the bathing solution measured by gas chromatography is illustrated in figure 1 .
Halothane was obtained from Hoechst AG (Frankfurt/Main, Germany), noradrenaline from Merck-Suchard (Hohenbrunn, Germany) and milrinone from Sterling Winthrop Group (Guildford, UK). All other compounds used were of analytical or best grade commercially available. Only deionized and twice distilled water was used throughout.
Statistical analysis
Data shown are mean (SEM). Statistical significance was estimated using Student's t test for unpaired observations and analysis of variance. P < 0.05 was considered significant. The drug concentrations producing 50 % of the maximum effect (EC W ) were determined graphically in each individual experiment using the linear equation. EC50 values are given with 95 % confidence limits.
RESULTS
There was a strong correlation between the concentration of halothane added to the carbogen and the concentration of halothane in the bathing 0 1 4% Hal. ) and its reversibility after withdrawal of the agent in an isolated, electrically driven (1 Hz, 37 °C) left ventricular muscle strip from a patient who had to undergo heart transplantation. Right panel: concentration-response curve for the effect of 0-4 % Hal. on isometric force of contraction in isolated, electrically driven ventricular strips from patients who had to undergo heart transplantation. Experiments on eight preparations from six hearts were carried out. Basal force of contraction:
3.2 (0.3) mN. solution measured by gas chromatography ( fig. 1) . Administration of 4% halothane (maximum concentration used) to papillary muscle strips resulted in a decline in the force of contraction of about 60%. This effect was rapidly reversible after removal of the anaesthetic from the gas mixture. The concentration-response curve for halothane shows that there was a concentration-dependent decrease in the force of contraction. The IC^ value for the negative inotropic effect was about 2% halothane. Figure 2 summarizes the negative inotropic effect of halothane on isolated human papillary muscle strips.
There was no change in pH (not shown). Figure 3 shows concentration-response curves illustrating the positive inotropic effect of noradrenaline, alone and in the presence of 2% halothane, which produced a reduction in inotropic effects of about 40 %. The efficacy of noradrenaline was enhanced in the presence of halothane, while the potency remained unchanged. Maximal effects and EQo values are summarized in table I.
In order to investigate if the "sensitizing" effect of halothane on catecholamines was related to an effect on cell surface receptors or to an increase in cAMP formation, we examined the effect of the cAMP phosphodiesterase inhibitor, milrinone. In the presence of halothane, the potency and efficacy of milrinone were enhanced by halothane ( fig. 3) . Values for maximum increase in force of contraction and ECso values are shown in table I.
At this stage of investigation, one could argue that the sensitizing effect of halothane may be nonspecific for positive inotropic agents. Therefore, we studied the effect of halothane on the positive inotropic effects of BayK 8644, an agonist at the Ltype Ca 2+ channel and the positive inotropic effect of an increase in extracellular Ca 2+ concentration. Halothane shifted the concentration-response curve of BayK 8644 to the right, but had no effect on the efficacy of the compound (fig. 3) . The potency and efficacy of Ca 2+ were not affected by halothane ( fig.  3) . Maximum effects and EG^, values are summarized in table I. DISCUSSION We have found that halothane had different and even opposing effects on the responses to various positive inotropic agents on isolated, human cardiac preparations.
Halothane alone exhibited a concentration-dependent negative inotropic effect. It should be noted that the concentration of halothane in the bathing solution was lower than would be predicted in an aqueous phase, possibly because measurement was carried out in a Tyrode salt-containing solution [7] . We found that halothane increased the efficacy of noradrenaline and also the potency and efficacy of milrinone; halothane shifted the concentration-response curve of BayK 8644 to the right but did not influence the efficacy of this agent or the efficacy and potency of Ca 2+ . Inhalation anaesthetics sensitize the myocardium to catecholamines in dogs [8] even at subanaesthetic concentrations [9] . It has been observed that halothane was effective in potentiating adrenalineinduced arrhythmias in man [3] . In this study, we found that halothane increased the efficacy of the positive inotropic effect of noradrenaline.
According to Sutherland, Robinson and Butcher [10] , any positive inotropic intervention associated with enhancement of cAMP formation is increased in potency when cAMP breakdown is inhibited by cAMP-phosphodiesterase inhibition. This was examined by investigating the effects of milrinone alone and in the presence of halothane in our study.
We found that not only the effect of noradrenaline but also the positive inotropic effect of milrinone was enhanced by halothane. Wright and Sherry [11] studied the influence of milrinone on haemodynamic variables in patients and reported an increase in cardiac index of about 35%, while Molter and colleagues [12] reported a 30% increase in cardiac index with enoximone. In the latter study halothane caused a decrease in cardiac index of about 20% compared with the control group. These findings contrast with the present study, although it should be noted that in the clinical studies, cardiac index was influenced by changes in heart rate, and pre-and afterload. In the present study, however, isolated human papillary muscle strips were studied without these confounding effects.
Our data provide evidence that halothane caused an increase in cAMP formation and therefore enhanced the positive inotropic effect of drugs which use cAMP as a second messenger to mediate inotropic effects. The unchanged potency of noradrenaline favours this suggestion because inhibition of cAMP breakdown produced by halothane would shift the concentration-response curve of noradrenaline to the left. The sensitizing effect of halothane is most likely to be caused by an action at the postsynaptic site because the positive inotropic effect of isoprenaline, which is not a substrate for uptake into presynaptic stores [13] , is also enhanced [14] . This is supported by reports that halothane increased the activity of adenylate cyclase in uterine membranes of rats [15] , in S 49 lymphoma cells and in human myocardial cell membranes [16, 17] . The latter study reported that the increase in adenylate cyclase activity was caused by inactivation of the inhibitory guanine nucleotide binding protein by halothane. Because the catecholamine sensitizing effect occurs even at subanaesthetic concentrations [9] , these mechanisms appear to be relevant in clinical situations.
Halothane has been suggested to act in a nonspecific way, by producing dehydration of phospholipid membranes [18] . Therefore, one could argue that pretreatment with halothane facilitates the entry of Ca 2+ ions into the cell in a non-specific way. In contrast with the latter suggestion, pretreatment with halothane did not diminish the potency of the positive inotropic effect of the L-type Ca 2+ agonist, BayK 8644. These findings provide evidence for an antagonist effect of halothane at the dihydropyridinesensitive Ca 2+ channel, by interacting with the open state of the L-type calcium channel [4] . In agreement with this suggestion are the findings of Blanck, Runge and Stevenson [19] , Drenger, Ruigg and Blanck [20] and Schmidt and colleagues [21] who reported that halothane reduced Ca 2+ channel antagonist binding to rat cardiac membranes, bovine cardiac membranes and human cardiac membranes, respectively. Halothane has been reported to produce a negative inotropic effect during anaesthesia in humans [1, 22] and preparations from guineapigs [2] , amphibians, rats [23] and ferrets [24, 25] . This negative inotropic effect has also been shown in in vitro studies of isolated human papillary muscle strips [21, present study] . We have presented evidence for an antagonist effect of halothane on the L-type Ca 2+ channel and this is likely to be involved in the negative inotropic effect of this agent.
In most previous animal studies, different functional and biochemical methods were used, providing contradictory results, and these could well be different from studies in humans [26] . The present investigation used the influence of halothane on the positive inotropic effect of Ca 2+ as a tool to investigate if the potential action of halothane on the contractile apparatus has functional consequences for the force development of the human myocardium. Halothane did not influence the efficacy or potency of Ca 2+ in human left ventricular trabeculae, indicating that an interaction between halothane with the contractile apparatus is not likely to have functional relevance for force generation in human myocardium.
In summary, in human ventricular myocardium, halothane enhanced the positive inotropic effect of noradrenaline and milrinone. The positive inotropic effect of Ca 2+ was not influenced by halothane and the concentration-response curve of BayK 8644 was shifted to the right. We conclude that halothane interacts specifically with different subcellular sites of the myocardial cell rather than producing nonspecific actions. The catecholamine "sensitizing effect" seems to be located at the level of the adenylate cyclase system. The diminished potency of the concentration-response curve of BayK 8644 in the presence of halothane shows the antagonist effect of halothane at the L-type Ca 2+ channel and may contribute to its negative inotropic effect. Therefore, experiments on the influence of halothane on isolated cardiac preparations after the addition of positive inotropic agents with different mechanisms of action may be used as a tool to localize different sites of action of inhalation anaesthetics in human myocardium.
